What are the calcium channel blockers?

In clinical trials, calcium channel blockers (CCBs) are commonly used medications that play a significant role in clinical treatment. So, what are the available calcium channel blockers?

What Are Calcium Channel Blockers?

Clinically, commonly used calcium channel blockers fall into two main categories: dihydropyridines and non-dihydropyridines. Non-dihydropyridine CCBs include phenylalkylamines (e.g., verapamil) and benzothiazepines (e.g., diltiazem). Dihydropyridine CCBs are predominantly used as antihypertensive agents. These dihydropyridine CCBs are further classified into four generations: the first-generation prototype is nifedipine; second-generation representatives include felodipine; third-generation agents include lacidipine and amlodipine; and fourth-generation examples include cilnidipine.

Calcium channel blockers constitute a class of drugs whose mechanism of action involves modulation of calcium ion channels in cardiac and large vascular smooth muscle cells. They are most frequently employed in the treatment of hypertension, arrhythmias, and other cardiovascular conditions. Since cardiac and vascular tissues possess intrinsic ion channels, physiological functions are regulated by maintaining appropriate intracellular and extracellular ion gradients. Calcium channel blockers reduce extracellular calcium influx into cells, thereby inhibiting myocardial cell contraction and decreasing intracellular calcium concentration in vascular smooth muscle. This results in lowered blood pressure, vasodilation, and suppression of myocardial contractility—ultimately achieving an antihypertensive effect.

In daily life, it is essential to prioritize self-protection and health maintenance to prevent various diseases that may impair quality of life and overall well-being. We hope this information proves helpful to you!